| Market Cap | — | |
| Enterprise Value | — | |
| Revenue | €266.8M | +4.2% |
| Gross Profit | €150.8M | +3.9% |
| EBITDA | €12.6M | +41.6% |
| Net Income | €13.4M | +99.9% |
| Diluted EPS | €0.23 | +109.1% |
| Free Cash Flow | €6.8M | −37.7% |
| Ratio | 2020 | 2021 | 2022 | 2023 | 2024 | Trend · 5y | vs own | vs sector |
|---|---|---|---|---|---|---|---|---|
| ▾Margins | ||||||||
| Gross Margin | 55.15% | 57.52% | 55.50% | 56.66% | 56.54% | 50% | 52% | |
| Operating Margin | −2.72% | 5.95% | −1.24% | 2.19% | 3.54% | 70% | 32% | |
| EBITDA Margin | −0.67% | 7.72% | 0.19% | 3.48% | 4.73% | 70% | 23% | |
| NOPAT Margin | −2.15% | 5.69% | −0.98% | 2.17% | 3.35% | 70% | 28% | |
| Net Margin | −4.13% | 6.40% | −0.91% | 2.62% | 5.04% | 70% | 37% | |
| FCF Margin | 11.12% | 8.72% | 0.29% | 4.26% | 2.55% | 30% | 27% | |
| FCFF Margin | — | 9.85% | — | 4.94% | 3.01% | 17% | 13% | |
| FCFE Margin | 3.06% | 1.77% | −7.34% | −2.26% | −6.17% | 30% | 20% | |
| OCF Margin | 17.59% | 12.58% | 9.61% | 7.87% | 11.79% | 50% | 36% | |
| Gross Profitability | 28.84% | 28.58% | 31.31% | 36.59% | 38.06% | 90% | 63% | |
| Capex Intensity | 6.47% | 3.86% | 9.31% | 3.61% | 9.24% | 70% | 88% | |
| ▸Returns on Capital · 6 ratios | ||||||||
| ▸DuPont factors (ROE drivers) · 4 ratios | ||||||||
| ▸Earnings quality · 7 ratios | ||||||||
| ▸Liquidity & coverage · 9 ratios | ||||||||
| ▸Leverage · 7 ratios | ||||||||
| ▸Working capital · 8 ratios | ||||||||
| ▸Capital allocation · 1 ratios | ||||||||
| ▸Per share · 3 ratios | ||||||||
| ▸Other · 1 ratios | ||||||||
The five drivers multiply to 5.4% vs reported ROE 5.5%. High ROE from margin and turnover is earned; from the equity multiplier it is borrowed.
| Line | 2020↗ | 2021↗ | 2022↗ | 2023↗ | 2024↗ |
|---|---|---|---|---|---|
| Revenue | €170.4M | €205.4M | €232.0M | €256.1M | €266.8M |
| YoY % | +20.5% | +12.9% | +10.4% | +4.2% | |
| Cost of Revenue | €76.4M | €87.3M | €103.3M | €111.0M | €115.9M |
| YoY % | +14.2% | +18.3% | +7.5% | +4.5% | |
| Gross Profit | €94.0M | €118.2M | €128.8M | €145.1M | €150.8M |
| YoY % | +25.7% | +9.0% | +12.7% | +3.9% | |
| R&D Expense | €27.1M | €26.9M | €37.6M | €38.1M | €44.4M |
| YoY % | -0.8% | +39.7% | +1.4% | +16.5% | |
| Selling & Marketing Expense | €44.6M | €49.2M | €62.1M | €57.8M | €61.6M |
| YoY % | +10.1% | +26.4% | -6.9% | +6.6% | |
| SG&A Expense | €29.3M | €33.3M | €35.1M | €37.1M | €39.6M |
| YoY % | +13.6% | +5.5% | +5.5% | +6.8% | |
| Operating Income | -€4.6M | €12.2M | -€2.9M | €5.6M | €9.4M |
| YoY % | +67.9% | ||||
| Interest Expense | €2.3M | €2.4M | €2.0M | €1.8M | €1.3M |
| YoY % | +5.9% | -15.9% | -14.5% | -25.8% | |
| Interest & Investment Income | €2.5M | €5.6M | €6.1M | €5.0M | €7.7M |
| YoY % | +129.2% | +8.8% | -17.9% | +53.0% | |
| Equity Method Income | -€39,000 | €0 | — | — | — |
| Pretax Income | -€8.2M | €13.7M | -€1.2M | €6.8M | €14.1M |
| YoY % | +108.8% | ||||
| Income Tax | -€1.0M | €591,000 | €975,000 | €78,000 | €733,000 |
| YoY % | +65.0% | -92.0% | +839.7% | ||
| Net Income (incl. NCI) | -€7.2M | €13.1M | -€2.2M | €6.7M | €13.4M |
| YoY % | +100.2% | ||||
| Minority Interest (P&L) | -€148,000 | -€9,000 | -€29,000 | -€27,000 | -€30,000 |
| Net Income | -€7.0M | €13.2M | -€2.1M | €6.7M | €13.4M |
| YoY % | +99.9% | ||||
| Net Income to Common | -€7.0M | €13.2M | -€2.1M | €6.7M | €13.4M |
| YoY % | +99.9% | ||||
| EPS (Basic) | -€0.13 | €0.23 | -€0.04 | €0.11 | €0.23 |
| YoY % | +109.1% | ||||
| EPS (Diluted) | -€0.13 | €0.23 | -€0.04 | €0.11 | €0.23 |
| YoY % | +109.1% | ||||
| Weighted Avg Shares (Basic) | 53,364 | 56,685 | 59.1M | 59.1M | 59.1M |
| YoY % | +6.2% | +104096.9% | +0.0% | 0.0% | |
| Weighted Avg Shares (Diluted) | 53,364 | 56,843 | 59.1M | 59.1M | 59.1M |
| YoY % | +6.5% | +103807.3% | +0.0% | +0.0% |
The sector classification is SIC-derived, not official GICS. Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
